Igene Biotechnology Inc (IGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-1994 | 12-1993 | 09-1993 | 06-1993 | 03-1993 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | N/A | N/A | N/A | 47 |
| Marketable Securities | 60 | 60 | 40 | 20 | 0 |
| Receivables | 120 | 80 | 8 | 10 | 14 |
| Inventories | N/A | N/A | N/A | N/A | 3 |
| Other current assets | 0 | 10 | 2 | 0 | 1 |
| TOTAL | $180 | $150 | $50 | $30 | $65 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 10 | 10 | 10 | 10 | 11 |
| TOTAL | $10 | $10 | $10 | $10 | $11 |
| Total Assets | $250 | $250 | $190 | $180 | $220 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 0 | 127 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 66 |
| Other current liabilities | N/A | N/A | N/A | N/A | 38 |
| TOTAL | $520 | $430 | $350 | $190 | $231 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,500 | 1,500 | 1,500 | 1,500 | 1,500 |
| Other Non-Current Liabilities | 0 | 0 | 6 | 6 | 0 |
| TOTAL | $1,500 | $1,500 | $1,506 | $1,506 | $1,500 |
| Total Liabilities | $2,020 | $1,930 | $1,850 | $1,690 | $1,731 |
| Shareholders' Equity | |||||
| Common Shares | 120 | 120 | 120 | 120 | 125 |
| Retained earnings | -19,350 | -19,260 | -19,100 | -18,930 | -18,710 |
| Other shareholders' equity | 10 | 20 | 20 | 20 | 422 |
| TOTAL | $-2,210 | $-2,110 | $-2,080 | $-1,930 | $-1,511 |
| Total Liabilities And Equity | $-190 | $-180 | $-230 | $-240 | $220 |